NEWS ARCHIVE

    
       
 

* Plan Launch for Cyprus of TOVETOL® IN Q2 2012







                       

 
 

* Plan Launch for Cyprus of SONETAC® IN Q2 2012


                       
 
 
* Plan Launch for Cyprus of REPRAT® IN Q2 2012

       
 
 

* Marketing Authorization obtained for AROTAN®
  (Leflunomide) in September 2011.



                                 

 
 
* Marketing Authorization obtained for  REPRAT®
  (Pantoprazole) in March 2011.

 
 

* RYCARDON® (Irbesartan) and CoRYCARDON®
  (Irbesartan/HTC) launched in Cyprus in January 2011.

 

Designed by ICT4 Business Solutions Ltd.

Terms Of Use | Privacy Statement
Copyright 2010 by DotNetNuke Corporation